Radiation Oncology/Corporate



Radiation Therapy FacilitiesEdit


  • Chicago; 2005 (7/2004) PMID 16078260 -- "Intensity-modulated radiation therapy use in the U.S., 2004." (Mell LK, Cancer. 2005 Sep 15;104(6):1296-303.)
    • Survey. 239 respondents. Random sample of U.S. radiation oncologists (65% response rate).
    • Outcome: IMRT use 73% (compared with 32% in 2002). Rationale for adoption normal tissue sparing (88%), dose escalation 85%, economic competition 62%. Further 91% of non-users planned to adopt IMRT in the future
    • Conclusion: IMRT use increased significantly since 2002

Treatment Planning SoftwareEdit